Nicaragua-PACT-header
Virtual meeting between Dunia Castillo, MD, (PACT Mentor for Nicaragua), the NMO board and Glenda Meléndez, MD, Director of the Blood Bank.

PACT in Nicaragua: partnering to improve access to care

COVID-19 has taken a toll on the bleeding disorders community, causing disruptions in the supply of treatment and care, and a shift in focus by national governments. Despite these challenging circumstances, the WFH has been able to support the efforts of the NMO in Nicaragua—the Asociación Nicaragüense de Hemofilia (ANH)—by implementing and strengthening partnerships with key stakeholders, both national and international. These efforts have allowed the ANH to continue to support its members throughout the pandemic.

Also available in: Français Español

The work done in Nicaragua was part of the WFH Path to Access to Care and Treatment (PACT) Program—an initiative designed to improve outreach and diagnosis and increase access to sustainable care for people with inherited bleeding disorders. Mentorship is being provided by Dunia Castillo, MD (Cuba).

PACT has brought many benefits to Nicaragua: knowledge-sharing on care delivery and patient registries has increased; a plan has been developed to create a network of centres that can provide primary care to patients living far from the capital city of Managua, where hemophilia treatment centres (HTCs) are based; there is active support for the NMO by the head of the Nicaraguan blood bank, Glenda Meléndez, MD; and treatment guidelines will be adapted to the national healthcare system.

Today, the Asociación Nicaragüense de Hemofilia (ANH), the Ministry of Health (MINSA) and the WFH are working very closely to develop the first National Hemophilia Treatment Guidelines that will make it possible to standardize the treatment of hemophilia at the national level

— Delvin Romero, ANH President, and a person with hemophilia A

To find out more about the WFH Path to Access to Care and Treatment (PACT) Program, please click here.

The PACT Program is supported by funding from Roche, our visionary partner; CSL Behring, Pfizer, and Sanofi Genzyme, our leadership partners, and Biotest, Grifols, and Sobi, our collaborating partners.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.